title: Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region.
authors.forename: J M
authors.initials: JM
authors.lastname: Liu
authors.forename: Y M
authors.initials: YM
authors.lastname: Chen
authors.forename: Y
authors.initials: Y
authors.lastname: Chao
authors.forename: T W
authors.initials: TW
authors.lastname: Liu
authors.forename: C M
authors.initials: CM
authors.lastname: Chou
authors.forename: L T
authors.initials: LT
authors.lastname: Chen
authors.forename: W L
authors.initials: WL
authors.lastname: Yu
authors.forename: J
authors.initials: J
authors.lastname: Whang-Peng
mesh_terms: D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy*; D017239:Paclitaxel / Q000009:adverse effects*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D011879:Radiotherapy Dosage
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel